Lakefront Biotherapeutics NV (LKFT)
NASDAQ: LKFT · Real-Time Price · USD
30.00
+0.68 (2.32%)
At close: Oct 7, 2026, 4:00 PM EDT
30.01
0.00 (0.02%)
After-hours: Oct 7, 2026, 7:30 PM EDT
Lakefront Biotherapeutics NV Employees
Lakefront Biotherapeutics NV had 196 employees as of June 30, 2026. The number of employees decreased by 256 or -56.64% since the number was reported on December 31, 2025.
Employees
196
Change
-256
Growth
-56.64%
Revenue / Employee
$5,773,962
Profits / Employee
$3,477,735
Market Cap
1.93B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 196 | -256 | -56.64% |
| Dec 31, 2025 | 452 | -252 | -35.80% |
| Dec 31, 2024 | 704 | -419 | -37.31% |
| Dec 31, 2023 | 1,123 | -215 | -16.07% |
| Dec 31, 2022 | 1,338 | 29 | 2.22% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Novavax | 749 |
| Agios Pharmaceuticals | 540 |
| Vir Biotechnology | 367 |
| Structure Therapeutics | 281 |
| Biohaven | 274 |
| Xencor | 260 |
| Zymeworks | 231 |
LKFT News
- 1 day ago - Acquisition of Own Shares - GlobeNewsWire
- 8 days ago - Acquisition of Own Shares - GlobeNewsWire
- 14 days ago - Lakefront Biotherapeutics Shares Jump 7.36% as Former Galapagos NV Continues Its Ongoing Corporate Reinvention - International Business Times (Australia)
- 14 days ago - Lakefront upgraded to Outperform from Sector Perform at RBC Capital - TheFly
- 15 days ago - Acquisition of Own Shares - GlobeNewsWire
- 16 days ago - Lakefront Biotherapeutics Targets 2027 Registrational Trials for Gamgertamig - MarketBeat
- 22 days ago - Lakefront Biotherapeutics NV Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 22 days ago - Acquisition of Own Shares - GlobeNewsWire